Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Visual Functional and Histopathological Correlation in Experimental Autoimmune Optic Neuritis.
Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants.
A phase II study of laquinimod in Crohn's disease.
Safety Study of GNbAC1 in Multiple Sclerosis Patients
Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosis.
High-field imaging of neurodegenerative diseases.
Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats.
Associations of CD6, TNFRSF1A, and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
Early bilateral cystoid macular oedema secondary to fingolimod in multiple sclerosis.
Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients.
Phenytoin (Dilantin) and acupuncture therapy in the treatment of intractable oral and facial pain.
The effects of massage therapy on multiple sclerosis patients' quality of life and leg function.
Extracranial Venous abnormalities: A true pathological finding in patients with multiple sclerosis or an anatomical variant?
Genzyme’s Lemtrada™ approved in Canada for treatment of multiple sclerosis
CLARITY – Safety and Efficacy of Oral Cladribine in Subjects with Relapsing-remitting Multiple Sclerosis (MS)
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
CHMP assessment report for Sovrima (International nonproprietary name: idebenone)
Santhera enters agreement with Columbia University to investigate additional potential of Catena® in MELAS
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey.
Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.
Exogenous schwann cells migrate, remyelinate and promote clinical recovery in experimental auto-immune encephalomyelitis.
B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.

Pages